The Food and Drug Administration approved the first drug designed specifically for postpartum depression treatment Tuesday.

Zulresso, Sage Therapeutics’ first product, is administered as an IV infusion by a professional in a certified healthcare facility. While the treatment lasts more than 60 hours, it reportedly starts working within days. Patients must be monitored during the treatment because of the risk of sedation or loss of consciousness.